Literature DB >> 19041637

Hydroxocobalamin and cyanocobalamin interference on co-oximetry based hemoglobin measurements.

Prasad V A Pamidi1, Marlene DeAbreu, Donghak Kim, Sohrab Mansouri.   

Abstract

BACKGROUND: Hydroxocobalamin (OHCbl) and cyanocobalamin (CNCbl) are dark-red colored analogs of vitamin B-12. OHCbl is used as an alternate antidote for cyanide poisoning. Due to the strong red color, if uncorrected, these cobalamins interfere with hemoglobin measurements and can introduce errors in spectrophotometric assay on co-oximeters. The impact of cobalamins on commonly used co-oximetry systems was compared to evaluate the accuracy of hemoglobin measurements and to further assess the ability of the instruments to detect and flag cobalamin interference.
METHODS: Blood samples spiked with varying concentrations of hydroxocobalamin or cyanocobalamin (0-2 g/l), were measured on 3 GEM Premier 4000 s, 3 IL 682 CO-Oximeter, 1 Radiometer ABL 735 and 1 Siemens Rapidpoint 405 analyzer. The effect of OHCbl or CNCbl interference on total hemoglobin and hemoglobin derivatives is evaluated using the measured difference between the control sample and the spiked sample.
RESULTS: Spectral measurements, blood measurements and delta spectral data confirmed that hemoglobin measurement accuracy is affected by the presence of OHCbl or CNCbl and that the source of interference is from errors in measurement algorithms, and not due to cobalamin induced hemoglobin changes.
CONCLUSIONS: Among the 4 co-oximeters tested in this evaluation, GEM Premier 4000 and Rapidpoint 405 analyzer showed minimal impact for hydroxocobalamin concentrations around 0.5 g/l. Cyanocobalamin displayed similar interference effect on co-oximetry measurements as OHCbl. The error detection system in the GEM Premier 4000 appropriately detected and flagged interferences on sample measurements.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041637     DOI: 10.1016/j.cca.2008.11.007

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Hemodialysis failure secondary to hydroxocobalamin exposure.

Authors:  Kenneth Lim; Eliot Heher; David Steele; Andrew Z Fenves; John Kevin Tucker; Ravi Thadhani; Kenneth Christopher; Nina Tolkoff-Rubin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  Wine-Colored Plasma and Urine from Hydroxocobalamin Treatment.

Authors:  Sophia L Wong; Morris Pudek; Dailin Li
Journal:  J Gen Intern Med       Date:  2016-06-23       Impact factor: 5.128

3.  High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm.

Authors:  Wisit Cheungpasitporn; John Hui; Kianoush B Kashani; Erica D Wittwer; Robert C Albright; John J Dillon
Journal:  Clin Kidney J       Date:  2017-03-15

4.  Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest.

Authors:  Gayle E Derfus; Jemelle Dizon-Maspat; Jared T Broddrick; Arleene C Velayo; Josh D Toschi; Rodell T Santuray; Stephen K Hsu; Charles M Winter; Rajesh Krishnan; Ashraf Amanullah
Journal:  MAbs       Date:  2014-02-19       Impact factor: 5.857

5.  Successful Renal Transplantation after Presumed Cyanide Toxicity Treated with Hydroxocobalamin and Review of the Literature.

Authors:  Ryan J Hendrix; Paulo N Martins; Jeffrey S Stoff; Aaron Ahearn; Adel Bozorgzadeh; Babak Movahedi
Journal:  Case Rep Transplant       Date:  2018-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.